We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Sakura Finetek Europe B,V.

Sakura Finetek provides integrated solutions for anatomic pathology and patients to advance cancer diagnostics. The c... read more Featured Products: More products

Download Mobile App




Sakura Finetek Launches New Advanced Staining System

By LabMedica International staff writers
Posted on 06 Sep 2022
Print article
Image: Tissue-Tek Genie is the first and only fully automated, true random access stainer for IHC and ISH (Photo courtesy of Sakura Finetek)
Image: Tissue-Tek Genie is the first and only fully automated, true random access stainer for IHC and ISH (Photo courtesy of Sakura Finetek)

Sakura Finetek Europe (The Netherlands) has launched its newest solution Tissue-Tek Genie, an advanced staining system. The Tissue-Tek Genie Advanced Staining System is the first and only fully automated, true random access stainer for immunohistochemistry (IHC) and in situ hybridisation (ISH); thanks to its innovative technology makes it uncompromisingly fast, providing a predictable case turnaround time. With this groundbreaking system, the company enters a new market. The launch of Genie demonstrates the company’s commitment to supporting the provision of the next-generation immunohistochemistry solution.

By continuous 3rd-party clinical validation performed by NordiQC, Sakura Finetek provides optimal scoring antibodies only, focusing on the optimal result for pathologists and their patients. Tissue-Tek Genie is extending Sakura’s wide range of standardizing pre-analytical instruments. The company has a long history of technological innovations. Sakura Finetek had launched the first fully enclosed tissue processor: Tissue-Tek VIP, the first rapid tissue processor: Tissue-Tek Xpress and the first automated embedding system: Tissue-Tek AutoTEC. The Tissue-Tek Genie fits perfectly in that line and brings enormous opportunities for future innovations.

“I’m thrilled and proud with the launch of this innovative solution,” said Chris Koeman, President of Sakura Finetek Europe. “This underlines our company’s mission: empowering pathology professionals to deliver accurate and fast diagnoses to optimize treatment success for each life we touch.”

“This is a next-generation advanced staining system, a game changer in the complex world of advanced staining,” said Mateo Iglesias, Vice-President of Marketing and Sales. “Genie drives quality and standardization of every single slide, allowing our customers to make a confident diagnostic decision with a system that will guarantee consistent and optimal results.”

Related Links:
Sakura Finetek Europe 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.